Renovalo S.p.A. (BIT:RNV)

Market Cap	20.05M
Revenue (ttm)	26.90M
Net Income (ttm)	596.36K
Shares Out	11.20M
EPS (ttm)	n/a
PE Ratio	33.62
Forward PE	17.90
Dividend	0.04 (1.92%)
Ex-Dividend Date	Jun 9, 2025

Volume	1,200
Average Volume	1,575
Open	1.800
Previous Close	1.800
Day's Range	1.800 - 1.825
52-Week Range	1.800 - 3.040
Beta	-0.20
RSI	39.24
Earnings Date	Mar 28, 2025

About Ligand Pharmaceuticals

Renovalo S.p.A. engages in the construction business in Italy. It operates as a general contractor for design and construction, and maintenance of condominium and energy projects; and undertakes urban regeneration and tall renovation projects. The company was formerly known as Imprendiroma S.p.A. and changed its name to Renovalo S.p.A. in June 2024. Renovalo S.p.A. was founded in 2008 and is based in Rome, Italy.

• Industry: Building Construction General Contractors and Operative Builders
• Founded: 2008
• Employees: 185
• Stock Exchange: Borsa Italiana
• Ticker Symbol: RNV

Financial Performance

In 2024, Renovalo's revenue was 26.90 million, a decrease of -78.27% compared to the previous year's 123.82 million. Earnings were 596,364, a decrease of -96.68%.